Gregory Hannon is Royal Society Professor of Molecular Cancer Biology at Cancer Research UK. He has played a substantial role in the discovery of cyclin dependent kinase inhibitors and in linking these to tumorigenesis, investigating both their biological roles and biochemical mechanisms. He contributed substantially to the current understanding of the mechanism of RNAi, including the discovery of Dicer and the content and mechanism of action of RISC. Professor Hannon always maintained an interest in technology and has developed a number of widely-used approaches. These include short hairpin RNAs, the production of oligonucleotide libraries by in situ synthesis, and genome-partitioning strategies.
Fellow
Back to directory listingProfessor Gregory Hannon FRS FMedSci
Job Title
Royal Society Professor of Molecular Cancer Biology
Institution
University of Cambridge
Year elected
2017
Interests
SpecialitiesMy lab focuses on non-coding RNA biology, cancer, epgigenetics, and technology development.
Section committee elected byCellular and developmental biology, microbiology and immunology, genetics
Online Information